At the 2014 Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis on May 28-31 in Dallas, Acorda Therapeutics will be demonstrating its award-winning MS self™ mobile app designed for patients with multiple sclerosis.
technology
Recommended Posts
- How functional dentistry can help to reduce immune and toxic stress
- Study connects lower levels of rare gut bacterium to higher MS risk
- Childhood trauma may affect treatment adherence in MS patients
- Like the spoon theory, the fork theory can also help explain MS
- 2 brain MRI markers may help ID MS patients at risk of cognitive decline